How to Help Your Patients Save Money on Hyrimoz: A Provider's Guide to Savings Programs

Cost is one of the most significant barriers to Hyrimoz adherence — and treatment interruptions due to cost put patients at real clinical risk. As a prescriber, understanding the savings landscape and knowing how to efficiently connect patients to the right programs can be the difference between successful long-term treatment and repeated access gaps.

This guide covers every major savings avenue available for Hyrimoz (adalimumab-adaz) in 2026, with actionable steps your practice can take to reduce patient cost burden efficiently.

Understanding the Hyrimoz Cost Landscape in 2026

The list price environment for Hyrimoz has evolved dramatically with the biosimilar market transformation:

Branded Hyrimoz: Approximately $3,500 to $6,500 per month at list price

Cordavis/unbranded Hyrimoz: Approximately $1,300 to $1,900 per month — the lowest list price adalimumab product available

With commercial insurance + copay program: As low as $0 per dose for eligible patients

Medicare patients: No access to manufacturer copay programs; rely on plan coverage and independent foundations

The key insight for providers: net cost to the patient is highly dependent on (1) which biosimilar is formulary preferred, (2) whether the copay program is accessed, and (3) whether the patient is on commercial vs. government insurance. Addressing all three systematically in your practice prevents the most common cost-related access failures.

Program 1: Sandoz One Source Co-Pay Program (Commercial Insurance)

The Sandoz One Source Co-Pay Program is the most impactful savings tool for commercially insured patients. Key details for provider offices:

Potential savings: Out-of-pocket as low as $0 per dose for eligible commercially insured patients

Eligibility: Commercial insurance only. Not available for Medicare (Part D), Medicaid, TRICARE, VA, DoD, or other government programs

Enrollment: Online at hyrimoz.com or by calling 1-833-497-4669; your staff can also enroll patients on their behalf

Limitations: Monthly and/or annual benefit caps may apply; accumulator adjustment programs (used by some insurers) may limit how copay assistance counts toward deductibles

Additional services: Sandoz One Source case managers also assist with benefits investigations, prior authorization (via CoverMyMeds integration), and specialty pharmacy enrollment — making this a one-stop support resource

Program 2: Sandoz Patient Assistance Program (Uninsured/Underinsured)

For patients without insurance or with insufficient coverage, Sandoz operates a patient assistance program (PAP) that can provide Hyrimoz at significantly reduced or no cost. This program requires income qualification and documentation. Your office can initiate the process through Sandoz One Source at 1-833-497-4669 or via hyrimoz.com. Sandoz case managers handle the paperwork with your office and the patient.

Program 3: Independent Co-Pay Foundations (All Insurance Types)

For patients on Medicare, Medicaid, or those who've exhausted manufacturer copay programs, independent non-profit foundations provide critical support. Your referral coordinator should have these resources readily available:

PAN Foundation (panfoundation.org): Disease-specific funds for RA, Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, and other adalimumab indications. Available to Medicare patients. Income-based eligibility.

HealthWell Foundation (healthwellfoundation.org): Co-pay assistance for various autoimmune conditions. Accepts Medicare patients. Fund availability varies by disease and year.

Patient Advocate Foundation (patientadvocate.org): Offers co-pay relief and case management services. Can also assist with insurance appeals.

NeedyMeds (needymeds.org): Comprehensive database of PAPs and co-pay programs. Useful for patients who don't fit any single program's criteria.

Strategy: Biosimilar Selection as a Cost Tool

One of the most underutilized cost management strategies is aligning biosimilar selection with the patient's formulary. In 2026:

CVS Caremark patients: Hyrimoz and Cordavis private-label versions are preferred — prescribe Hyrimoz or adalimumab-adaz generically

Express Scripts patients: Cyltezo (adalimumab-adbm) may be preferred — consider prescribing Cyltezo or adalimumab generically

Prescribing the formulary-preferred biosimilar can eliminate or dramatically reduce the need for prior authorization appeals and patient out-of-pocket costs

Practice Workflow: Integrating Cost Navigation into Your Process

Consider implementing the following workflow in your practice to systematically reduce patient cost burden:

Benefits verification: Before prescribing, verify the patient's insurance formulary for adalimumab coverage. Identify the preferred biosimilar on their plan.

Copay program enrollment: Enroll commercially insured patients in the Sandoz One Source copay program at point of prescribing, not after they hit a cost barrier.

Medicare/Medicaid patients: Immediately route to PAN Foundation or HealthWell Foundation. Document income information at the visit to facilitate foundation applications.

Prior authorization: Submit PA through CoverMyMeds at prescribing. Track expirations and submit renewals 60+ days in advance.

Annual formulary review: Each January, proactively review adalimumab-using patients for insurance formulary changes that could create access or cost problems.

Addressing the Accumulator Adjustment Problem

Some insurers use accumulator adjustment programs that prevent manufacturer copay assistance from counting toward the patient's deductible. This can create a "deductible cliff" where patients pay nothing during copay program coverage but then face the full deductible once the manufacturer benefit is exhausted.

When counseling patients: alert them to check whether their plan uses an accumulator. If so, connect them with Sandoz One Source to discuss the implications and explore alternatives. Some states have passed laws restricting accumulator programs, so local regulations may affect this.

For a patient-facing resource you can share at your practice, see our guide: How to Save Money on Hyrimoz in 2026.

To help your patients find Hyrimoz in stock when specialty pharmacy delays occur, your staff can use medfinder.com/providers to quickly locate nearby pharmacies with the medication available.